Table 2. Prevalence and odds ratio of health condition groups in adults with atrial fibrillation compared to adults without atrial fibrillation.
| Health condition | Adults with AF n (%) (N=34,338) |
Adults without AF n (%) (N=907,739) |
Unadjusted OR (95%CI) |
OR adjusted for age and sex (95%CI) |
OR adjusted for age, sex and IMD (95%CI) |
|---|---|---|---|---|---|
| Abnormal lipid level | 17906 (52.1) | 360518 (39.7) | 1.65 (1.62-1.69) | 0.49 (0.47-0.50) | 0.48 (0.47-0.50) |
| Benign neoplasm | 7957 (23.2) | 115993 (12.8) | 2.06 (2.01-2.11) | 1.07 (1.04-1.10) | 1.08 (1.05-1.11) |
| Cardiovascular | 30688 (89.4) | 236587 (26.1) | 23.85 (23.04-24.70) | 5.82 (5.60-6.05) | 5.81 (5.59-6.03) |
| Dermatological | 16735 (48.7) | 387303 (42.7) | 1.28 (1.25-1.31) | 1.43 (1.40-1.46) | 1.44 (1.40-1.47) |
| Ear nose throat disorder | 14770 (43.0) | 279142 (30.8) | 1.70 (1.66-1.74) | 1.23 (1.20-1.26) | 1.24 (1.21-1.27) |
| Endocrine and diabetes | 13395 (39.0) | 143622 (15.8) | 3.40 (3.33-3.48) | 1.55 (1.51-1.59) | 1.54 (1.50-1.58) |
| Eye disorder | 16494 (48.0) | 119496 (13.2) | 6.10 (5.96-6.23) | 1.42 (1.39-1.46) | 1.42 (1.38-1.45) |
| Gastrointestinal | 21246 (61.9) | 337617 (37.2) | 2.74 (2.68-2.80) | 1.34 (1.31-1.38) | 1.34 (1.31-1.37) |
| Genito urinary | 14029 (40.9) | 151612 (16.7) | 3.45 (3.37-3.52) | 1.23 (1.20-1.26) | 1.23 (1.20-1.26) |
| Gynaecological | 4885 (14.2) | 157731 (17.4) | 0.79 (0.76-0.81) | 0.82 (0.79-0.85) | 0.82 (0.79-0.85) |
| Haematological | 9987 (29.1) | 103393 (11.4) | 3.19 (3.11-3.27) | 1.93 (1.88-1.98) | 1.92 (1.87-1.97) |
| Infectious disease | 16254 (47.3) | 122871 (13.5) | 5.74 (5.62-5.87) | 3.14 (3.07-3.22) | 3.13 (3.06-3.21) |
| Liver disorder | 1149 (3.3) | 13067 (1.4) | 2.37 (2.23-2.52) | 1.48 (1.38-1.57) | 1.45 (1.36-1.55) |
| Mental health | 14001 (40.8) | 286717 (31.6) | 1.49 (1.46-1.52) | 1.26 (1.23-1.29) | 1.24 (1.21-1.27) |
| Neurological | 7454 (21.7) | 135081 (14.9) | 1.59 (1.54-1.63) | 1.30 (1.27-1.34) | 1.30 (1.26-1.33) |
| Orthopaedic | 19856 (57.8) | 213466 (23.5) | 4.46 (4.36-4.56) | 1.32 (1.29-1.35) | 1.32 (1.28-1.35) |
| Primary dermatological malignancy | 4183 (12.2) | 28496 (3.1) | 4.28 (4.13-4.43) | 1.09 (1.05-1.14) | 1.10 (1.06-1.14) |
| Primary haematological malignancy | 825 (2.4) | 5705 (0.6) | 3.89 (3.61-4.19) | 1.48 (1.37-1.60) | 1.48 (1.37-1.60) |
| Primary solid organ malignancy | 5217 (15.2) | 41481 (4.6) | 3.74 (3.63-3.86) | 1.06 (1.03-1.10) | 1.07 (1.03-1.10) |
| Renal | 18617 (54.2) | 111990 (12.3) | 8.41 (8.23-8.60) | 2.22 (2.17-2.28) | 2.21 (2.16-2.27) |
| Respiratory | 14702 (42.8) | 186492 (20.5) | 2.90 (2.83-2.96) | 2.52 (2.46-2.58) | 2.51 (2.45-2.57) |
| Rheumatological | 17325 (50.5) | 252637 (27.8) | 2.64 (2.58-2.70) | 1.03 (1.01-1.06) | 1.04 (1.01-1.06) |
| Secondary malignancy | 1261 (3.7) | 9791 (1.1) | 3.50 (3.29-3.71) | 1.06 (1.00-1.13) | 1.06 (0.99-1.13) |